P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population

Oncology Reports

Volumn 11, Issue 5, 2004, Pages 1115-1120

  Shen, Hongbing ^a   Solari, Ana ^b   Wang, Xinru ^a   Zhang, Zhengdong ^a,b   Xu, Yaochu ^a   Wang, Liwei ^c   Hu, Xu ^d   Guo, Jiantao ^e   Wei, Qingyi ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS   (United States)

^c Yangzhong Cancer Research Institute   (China)

^d Huaian Center for Disease Control and Prevention   (China)

^e JinTan Ctr Dis Contr and Prev   (China)

Author keywords

Gastric cancer; Genetic susceptibility; Genotype; Molecular epidemiology; p53

Indexed keywords

PROLINE; PROTEIN P53;

ADULT; AGED; ARTICLE; ASIAN; CHINA; CODON; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; STOMACH TUMOR;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CODON; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROLINE; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 16544365295     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.5.1115     Document Type: Article

References (39)

1. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543, 2001.
2. Pisani P, Parkin DM, Bray F and Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 18-29, 1999. (Pubitemid 29409471)
3. Stadtlander CT and Waterbor JW: Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 20: 2195-2208, 1999.
4. Kelley JR and Duggan JM: Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56: 1-9, 2003. (Pubitemid 36183309)
5. Pool-Zobel BL, Bub A, Muller H, Wollowski I and Rechkemmer G: Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoid-rich foods. Carcinogenesis 18: 1847-1850, 1997. (Pubitemid 28134695)
6. Takezaki T, Gao CM, Ding JH, Liu TK, Li MS and Tajima K: Comparative study of lifestyles of residents in high and low risk areas for gastric cancer in Jiangsu Province, China: with special reference to allium vegetables. J Epidemiol 9: 297-305, 1999.
7. Galanis DJ, Lee J and Kolonel LN: The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer 79: 1840-1841, 1997. (Pubitemid 27176369)
8. Zhang Z, Kurtz RC, Klimstra DS, et al: Helicobacter pylori infection on the risk of stomach cancer and chronic atrophic gastritis. Cancer Detect Prev 23: 357-367, 1999. (Pubitemid 29432338)
9. Kato S, Onda M, Matsukura N, et al: Helicobacter pylori infection and genetic polymorphisms for cancer-related genes in gastric carcinogenesis. Biomed Pharmacother 51: 145-149, 1997. (Pubitemid 27198726)
10. Setiawan VW, Zhang Z, Yu G, Li Y, Lu M, Tsai C and Cordova D: GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev 9: 73-80, 2000. (Pubitemid 30062912)
11. Hemminki K and Jiang Y: Familial and second gastric carcinomas: a nationwide epidemiologic study from Sweden. Cancer 94: 1157-1165, 2002. (Pubitemid 34150872)
12. El-Rifai W and Powell SM: Molecular biology of gastric cancer. Semin Radiat Oncol 12: 128-140, 2002. (Pubitemid 34522349)
13. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991. (Pubitemid 21917115)
14. Birch JM, Blair V, Kelsey AM, Evans DG, Harris M, Tricker KJ and Varley JM: Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene 17: 1061-1068, 1998. (Pubitemid 28444590)
15. Haber DA and Fearon ER: The promise of cancer genetics. Lancet 351: 1-8, 1998.
16. Storey A, Thomas M, Kalita A, et al: Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234, 1998. (Pubitemid 28261713)
17. Dumont P, Leu JI, Della Pietra AC III, George DL and Murphy M: The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33: 357-365, 2003. (Pubitemid 36278852)
18. Helland A, Langerod A, Johnsen H, Olsen AO, Skovlund E and Borresen-Dale AL: p53 polymorphism and risk of cervical cancer. Nature 396: 530-531, 1998.
19. Shepherd T, Tolbert D, Benedetti J, et al: Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology 118: 1039-1044, 2000. (Pubitemid 30346980)
20. Hiyama T, Tanaka S, Kitadai Y, et al: p53 codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer 100: 304-308, 2002. (Pubitemid 34728988)
21. Zhang Z, Newcomb P, Hollowood A, et al: Age-associated increase of codon 72 arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res 9: 2151-2156, 2003. (Pubitemid 36687637)
22. Shen H, Xu Y, Qian Y, et al: Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer 88: 601-606, 2000.
23. Kawajiri K, Nakachi K, Imai K, Watanabe J and Hayashi S: Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14: 1085-1089, 1993. (Pubitemid 23193532)
24. Shen H, Zheng Y, Sturgis EM, Spitz MR and Wei Q: P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett 183: 123-130, 2002. (Pubitemid 34628415)
25. Kaelin WG Jr: The p53 gene family. Oncogene 18: 7701-7705, 1999.
26. Robles AI and Harris CC: p53-mediated apoptosis and genomic instability diseases. Acta Oncol 40: 696-701, 2001. (Pubitemid 33081977)
27. Wang JY, Lin SR, Hsieh JS, Hsu CH, Huang YS and Huang TJ: Mutations of p53 gene in gastric carcinoma in Taiwan. Anticancer Res 21: 513-520, 2001. (Pubitemid 32267564)
28. Thomas M, Pim D and Banks L: The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 18: 7690-7700, 1999. (Pubitemid 30052696)
29. Marin MC, Jost CA, Brooks LA, et al: A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 25: 47-54, 2000. (Pubitemid 30257035)
30. Josefsson AM, Magnusson PK, Ylitalo N, Quarforth-Tubbin P, Ponten J, Adami HO and Gyllensten UB: p53 polymorphism and risk of cervical cancer. Nature 396: 531-532, 1998.
31. Zehbe I, Voglino G, Wilander E, et al: p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res 61: 608-611, 2001. (Pubitemid 32128622)
32. Andersson S, Rylander E, Strand A, Sallstrom J and Wilander E: The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas. Br J Cancer 85: 1153-1156, 2001. (Pubitemid 33052314)
33. Wu X, Zhao H, Amos CI, et al: p53 Genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst 94: 681-690, 2002. (Pubitemid 34552489)
34. Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK and Christiani DC: The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 10: 1037-1042 2000.
35. Henner WD, Evans AJ, Hough KM, Harris EL, Lowe BA and Beer TM: Association of codon 72 polymorphism of p53 with lower prostate cancer risk. Prostate 49: 263-266, 2001. (Pubitemid 33117001)
36. Soulitzis N, Sourvinos G, Dokianakis DN and Spandidos DA: p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 179: 175-183, 2002. (Pubitemid 34215109)
37. Sourvinos G, Rizos E and Spandidos DA: p53 codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumours. Oral Oncol 37: 572-578, 2001. (Pubitemid 32889619)
38. Bastiaens MT, Struyk L, Tjong-A-Hung SP, et al: Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: a need for screening? Mol Carcinog 30: 56-61, 2001. (Pubitemid 32127350)
39. Li T, Lu ZM, Guo M, et al: p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer 95: 2571-2576, 2002. (Pubitemid 35424044)